Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma

被引：26
|
作者：
Verburg, Frederik A. [1 ]
Dietlein, Markus [2 ]
Lassmann, Michael [1 ]
Luster, Markus [3 ]
Reiners, Christoph [1 ]
机构：
[1] Univ Clin Wurzburg, Dept Nucl Med, D-97080 Wurzburg, Germany
[2] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
[3] Univ Hosp Ulm, Dept Nucl Med, Ulm, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷 / 03期
关键词：
Endocrinology; Oncology; Radionuclide therapy; Ablation; Thyroid carcinoma; Radioiodine; 2ND PRIMARY MALIGNANCIES; RADIOACTIVE IODINE; CANCER VERSION-3; PRIMARY TUMORS; FOLLOW-UP; THERAPY; PAPILLARY; I-131; MANAGEMENT; RISK;
D O I：
10.1007/s00259-008-0997-5
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：343 / 346
页数：4
相关论文
共 50 条
  • [1] Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma
    Frederik A. Verburg
    Markus Dietlein
    Michael Lassmann
    Markus Luster
    Christoph Reiners
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [2] The efficacy of radioiodine remnant ablation for differentiated thyroid carcinoma patients with an incomplete thyroidectomy
    Fu, Hongliang
    Ma, Chao
    Li, Jianing
    Feng, Fang
    Wu, Shuqi
    Ye, Zhiyi
    Wang, Hui
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 60 (03): : 280 - 284
  • [3] Editorial: Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation
    Haugen, BR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3665 - 3667
  • [4] Analysis of Critical Parameters for Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Carcinoma
    Mika, A. Valkovic
    Nekic, J.
    Ivankovic, S. Grbac
    Valkovic, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S482 - S482
  • [5] Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: A randomized clinical trial in 509 patients
    Bal, CS
    Kumar, A
    Pant, GS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04): : 1666 - 1673
  • [6] Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma
    Hay, Ian D.
    McDougall, I. Ross
    Sisson, James C.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (08): : 1395 - 1397
  • [7] Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma
    Long, Bin
    Li, Linfa
    Yao, Lifang
    Chen, Shoucong
    Yi, Heqing
    Ye, Xuemei
    Xu, Dong
    Wu, Peng
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (08) : 244 - 247
  • [8] Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
    Prpic, Marin
    Dabelic, Nina
    Stanicic, Josip
    Jukic, Tomislav
    Milosevic, Milan
    Kusic, Zvonko
    [J]. ANNALS OF NUCLEAR MEDICINE, 2012, 26 (09) : 744 - 751
  • [9] Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
    Marin Prpic
    Nina Dabelic
    Josip Stanicic
    Tomislav Jukic
    Milan Milosevic
    Zvonko Kusic
    [J]. Annals of Nuclear Medicine, 2012, 26 : 744 - 751
  • [10] Radioiodine low-dose for remnant ablation in differentiated thyroid carcinoma: considerations of a pilot study
    Burroni, L.
    Castagna, M. G.
    Cipri, C.
    Pacini, F.
    Vattimo, A. G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S421 - S421
12345